Study S002248

The Effect of Exenatide on Body Weight, Energy Expenditure and Hunger in Obese Women Without Diabetes Mellitus

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

Included trial: extracted data ClinicalTrials.gov record

Registration

Registration: NCT00456885
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE4
Masking: DOUBLE
Status: COMPLETED
Enrollment: 41
Start: 2007-04
Primary completion: 2010-09
Lead sponsor: Beth Israel Deaconess Medical Center
Conditions: Obesity; Impaired Glucose Tolerance
Interventions: DRUG:exenatide; DRUG:Placebo
Results posted: TRUE
Secondary identifiers: OTHER:BFA912

Registered primary outcomes

Change in Weight [16 weeks after the beginning of each treatment]
Change in Body Mass Index [16 weeks from the start of each treatment period.]

Linked records (1)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

Record	Title	Year	Design	Identifiers	Link basis
R0017547	Short-term exenatide treatment leads to significant weight loss in a subset of obese women without diabetes. Dushay J, Diabetes care	2012	Randomized trial	PMID 22040840 DOI	registry reference RESULT:22040840